Drug intelligence / Profile preview

[68Ga]Ga-rhPSMA-10.1

Development stage
Unknown
Lead developer
Blue Earth Therapeutics
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[68Ga]Ga-rhPSMA-10.1 is a radiopharmaceutical agent consisting of a “radiohybrid” small molecule ligand labeled with gallium-68, designed for PET imaging of prostate-specific membrane antigen (PSMA)-expressing cancers. It binds with high affinity to PSMA, a membrane protein commonly overexpressed in prostate cancer cells and tumor neovasculature. Upon intravenous administration, the compound targets PSMA-positive lesions, enabling sensitive tumor localization with PET. The radiohybrid scaffold allows labeling with diagnostic radionuclides such as ^68^Ga for imaging or other radionuclides for therapy. Preclinical and translational studies indicate it provides high tumor uptake and favorable pharmacokinetics for both imaging and dosimetry, applicable for prostate cancer staging, recurrence detection, and possibly other PSMA-expressing tumors[3].

Brand names
[68Ga]Ga-rhPSMA-10.1
Other names
gallium-68 rhPSMA-10.1gallium68 rhPSMA-10.1gallium 68 rhPSMA-10.1
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on [68Ga]Ga-rhPSMA-10.1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-rhPSMA-10.1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call